[Priapism after intracavernous injection of PgE1 in two cases of impotence following total cysto-prostatectomy].
The authors report two cases of priapism of more than six hours, following intracavernous injection of 15 and 10 mcg PgE1 respectively, in six patients with impotence after radical cystoprostatectomy. Bearing in mind the proven safety of intracavernous injection of PgE1 in the treatment and diagnosis of erectile dysfunction, such a proportion of priapism in this group of patients has called our attention. It is probably due to an increased in the PgE1 intracavernous metabolism, due to the ligation of the penile venous drainage during surgery.
Llopis
J
J
Service d'Urologie et de transplantation rénale, Université de Barcelone, Hospital Clinic i Provincial Barcelona, Espagne.
Romero
J A
JA
Gutiérrez
R
R
Alvarez
R
R
Talbot
R
R
Vendrell
J R
JR
Barranco
M A
MA
Carretero
P
P
D000527:Alprostadil / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004837:Epinephrine / Q000008:administration & dosage / Q000627:therapeutic use*; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011317:Priapism / Q000139:chemically induced* / Q000188:drug therapy; D011468:Prostatectomy / Q000009:adverse effects*; D001749:Urinary Bladder Neoplasms / Q000601:surgery
D000527:Alprostadil; D004837:Epinephrine
Priapisme après injection intracaverneuse de PgE1 dans deux cas d'impuissance après cystoprostatectomie totale.